Resources

An overview of topical drug product forms – Part 2

An overview of topical drug product forms – Part 2

In part two of these blog posts authored by Dr. David Barnes and Lonnie Barish, we will discuss the various types of topical products (ointments, creams, gels, sprays, and lotions), detailing their characteristics both in terms of formulation and use. As discussed earlier, there has been an increase in the development of topical drug products as a way to deliver drugs locally to those surfaces,...

read more
How to reduce change orders in your product’s tech transfer

How to reduce change orders in your product’s tech transfer

In pharmaceutical contract manufacturing, outsourcing your product to the right Contract Development and Manufacturing Organization (CDMO) can be a daunting and concerning task. After conducting the legwork of determining the best fit for a CDMO from capabilities and organizational fit perspective, the next step is working with that vendor on determining costs. Generally speaking, there is a ton...

read more
An overview of topical drug product forms – Part 1

An overview of topical drug product forms – Part 1

There has been increased interest in the development of topical drug products as a way to deliver drugs locally, rather than systemically and for diseases that occur in the skin, mucosal surfaces, the eye, and/or wounds of these surfaces. There are reduced side effects and toxicity to other organs compared to systemic delivery. Topical drug products are typically formulated to enable the...

read more
KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to manufacture generic product for filing in Japan.

KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to manufacture generic product for filing in Japan.

KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals for the manufacturing of generic product for filing in Japan. KYOWA will be the first Japanese client for Bora’s Zhunan manufacturing site which is already USFDA, MHRA, and TFDA approved. This project will...

read more

Get the industry insights you care about

Join 3000+ subscribers and receive BORA resources in your inbox.

Resources by Category